Steve Faraci is Executive Director at the Research Technology Center (RTC) in Cambridge, Massachusetts. He joined Pfizer Central Research in Groton, CT in 1988 as a Research Scientist in the New Leads Department, which was pioneering the use of high throughput screening. In 1999, he relocated to the Discovery Technology Center (DTC) in Cambridge, MA as head of the Drug Pfinder program and Screening Technologies group. Recently, the DTC has transitioned to the RTC, whose role is to address specific challenges at the heart of drug discovery and development by using Pfizer’s scale and knowledge as well as partnering with scientific innovators in the Greater Boston community.

Steve received his BS in Chemistry from Fairfield University and his PhD in Chemistry from Wesleyan University. He then continued his training as a NIH Postdoctoral Fellow in the laboratory of Professor Christopher Walsh at MIT and Harvard Medical School.